info icon

This is a non-core endpoint: only basic statistics are computed.

Melanocytic naevi, other sites/unspecified (controls excluding all cancers)

CD2_BENIGN_MELANOCYTIC_NOS_EXALLC

No definition available.

Endpoint definition

FinnGen phenotype data

individuals

diagram downward connector

Apply sex-specific rule None

diagram downward connector

Check conditions None

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D22.9&
Hospital discharge: ICD-9 216[8-9]A
Cause of death: ICD-10 D22.9&
Cause of death: ICD-9 216[8-9]A

2 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector

Include endpoints None

-

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

2258

diagram downward connector
CD2_BENIGN_MELANOCYTIC_NOS_EXALLC

Control definitions

Control exclude C3_CANCER

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D22
Name in latin Naevus melanocyticus non specificatus

Summary Statistics

Key figures

All Female Male
Number of individuals 2258 1389 869
Unadjusted prevalence (%) 0.55 0.60 0.48
Mean age at first event (years) 51.25 47.14 57.83

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: CD2_BENIGN_MELANOCYTIC_NOS_EXALLC – Melanocytic naevi, other sites/unspecified (controls excluding all cancers)
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Melanocytic naevi, other sites/unspecified (controls excluding all cancers)

Endpoint not on priority list, no data to show.